| Title : Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium - Lakehal_1999_Hepatology_30_1498 |
| Author(s) : Lakehal F , Wendum D , Barbu V , Becquemont L , Poupon R , Balladur P , Hannoun L , Ballet F , Beaune PH , Housset C |
| Ref : Hepatology , 30 :1498 , 1999 |
| Abstract : |
| PubMedSearch : Lakehal_1999_Hepatology_30_1498 |
| PubMedID: 10573530 |
| Title : Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man - Becquemont_1998_Pharmacogenet_8_101 |
| Author(s) : Becquemont L , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P , Beaune P |
| Ref : Pharmacogenetics , 8 :101 , 1998 |
| Abstract : |
| PubMedSearch : Becquemont_1998_Pharmacogenet_8_101 |
| PubMedID: 10022747 |
| Title : Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans - Becquemont_1997_Clin.Pharmacol.Ther_61_619 |
| Author(s) : Becquemont L , Ragueneau I , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P |
| Ref : Clinical Pharmacology & Therapeutics , 61 :619 , 1997 |
| Abstract : |
| PubMedSearch : Becquemont_1997_Clin.Pharmacol.Ther_61_619 |
| PubMedID: 9209244 |
| Title : Glutathione S-transferase theta genetic polymorphism might influence tacrine hepatotoxicity in Alzheimer's patients - |
| Author(s) : Becquemont L , Lecoeur S , Simon T , Beaune P , Funck-Brentano C , Jaillon P |
| Ref : Pharmacogenetics , 7 :251 , 1997 |
| PubMedID: 9241666 |
| Title : Influence of fluvoxamine on tacrine metabolism in vitro: potential implication for the hepatotoxicity in vivo - |
| Author(s) : Becquemont L , Le Bot MA , Riche C , Beaune P |
| Ref : Fundamental & Clinical Toxicology , 10 :156 , 1996 |
| PubMedID: 8737959 |